Target intelligence / Profile preview

Nanog homeobox pseudogene 4 (NANOGP4)

Target
NANOGP4
Molecular classification
Pseudogene, Homeobox gene–derived sequence, Other (not a transcription factor or receptor itself)
01

Overview

Nanog homeobox pseudogene 4 (NANOGP4, also annotated as NANOGP2) is one of several NANOG-derived pseudogenes in the human genome, specifically a processed pseudogene located on chromosome 7p15.1[3]. Unlike the canonical Nanog gene (NANOG), which encodes a crucial homeobox transcription factor involved in embryonic stem cell pluripotency and self-renewal, NANOGP4 does not produce a functional protein and is not believed to serve as a transcription factor or to have a direct biological or disease-related function[3][2][4][5]. The gene is most commonly referenced in genomic surveys and classifications of the homeobox gene family, where it is consistently described as a pseudogene—a segment of DNA resembling a gene, but generally non-functional due to mutations or lack of regulatory elements[3][4]. Alternative names (aliases) include NANOGP2 and Nanog homeobox pseudogene 2, reflecting inconsistent historical nomenclature[3]. In summary, NANOGP4 is not a viable pharmacological or therapeutic target, and should not be confused with functional Nanog paralogs such as NANOG or NANOGP8, which are actively involved in stem cell biology and cancer[1][2][4]. The target you named, "NANOGP4" (also called "NANOGP2"), is not a functional protein or therapeutic target; it is a pseudogene. References to it as a target or candidate for intervention in biological or disease processes are incorrect[3][4]. The only functional human *Nanog*-related transcription factors are encoded by NANOG and possibly by NANOGP8 in certain cancers[1][2][3][4][5].

Other names
NANOGP2Nanog pseudogene 4Nanog homeobox pseudogene 2

Beyond the preview

Go deeper on Nanog homeobox pseudogene 4 (NANOGP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanog homeobox pseudogene 4 (NANOGP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call